7 results on '"Mukai, Hirofumi"'
Search Results
2. Effectiveness and safety of eribulin in Japanese patients with HER2-negative, advanced breast cancer: a 2-year post-marketing observational study in a real-world setting
3. Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study
4. Long-term combination chemotherapy using eribulin and trastuzumab for three patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
5. Phase 1 combination study of Eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer.
6. O1-9-4 A prospective real-world study of eribulin for HER2-negative recurrent breast cancer patients: final results.
7. MO1-8-4 Baseline neutrophil to lymphocyte ratio is predictor of longer OS of metastatic BC patients treated with eribulin.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.